This effect was confirmed in multivariate analysis (p < 0.01), which also revealed a significant difference in levels of CSF KIF5A between CIS and progressive MS samples when accounting for additional independent cohort variables (p < 0.01; Table 4). This evidence concerns the gene KIF5A and in situ carcinoma.